Position in ABVX
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$1,314,152
-$196,224 QoQ
Shares Held
11,802
+5.4% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.36%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ABVX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026AdvisorShares Investments LLC holds $17,592,416 across 20 Biotechnology names. ABVX ranks #5 (7.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RLMD |
Relmada Therapeutics, Inc.
|
295,872 | $2,059,269 | |
| 2 | ATAI |
AtaiBeckley Inc.
|
567,587 | $2,009,257 | |
| 3 | DFTX |
Definium Therapeutics, Inc.
|
91,301 | $1,725,588 | |
| 4 | ASND |
Ascendis Pharma A/S
|
5,750 | $1,315,197 | |
| 5 | ABVX |
Abivax S.A.
This page
|
11,802 | $1,314,152 | |
| 6 | DBVT |
DBV Technologies S.A.
|
50,340 | $1,051,602 | |
| 7 | GHRS |
GH Research PLC
|
67,034 | $942,498 | |
| 8 | HELP |
Cybin Inc.
|
195,604 | $938,899 |
All Filings in ABVX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,314,152 | 11,802 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $1,510,376 | 11,200 | Shares | Sole | 2026-02-10 | |
| No filing history on record for this holder in this stock. | ||||||